MM-151

· Merrimack Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MM-151, covering 2017-01-11 to 2018-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment [Phase 1]